Ainos, Inc. AIMD
Inc. (the "Company"), incorporated in the State of Texas in 1984, is a dual-platform company advancing artificial intelligence–based
smelltech technologies and immune therapeutics. Our primary strategic focus is the commercialization of our proprietary scent digitization
platform, AI Nose, while we also continue to develop therapeutic assets based on our low-dose oral interferon program, VELDONA®.
core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial
Last close
0.84
2026-10-23
Market cap
$6.2M
2026-06-30 share count
52-week range
0.79 - 3.88
Valuation FY2025 figures against the last close
P/S49.8x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-3.46
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $124.2K | $20.7K | $122.1K | $3.5M | $594.6K | $16.6K | $11.7K | $77.7K | $250.9K | — |
| Cost of revenue | $21.2K | $52.6K | $375.8K | $2.1M | $184.2K | $11.3K | $8.8K | $64.9K | $60.3K | — |
| Gross profit | $102.9K | -$31.9K | -$253.7K | $1.4M | $410.4K | $5.3K | $3.0K | $12.8K | $190.6K | — |
| R&D | $7.7M | $8.4M | $7.3M | $6.8M | $1.9M | $389 | $52.5K | $32.6K | — | — |
| SG&A | $6.3M | $5.4M | $5.6M | $8.5M | $2.4M | $1.4M | $1.5M | $1.3M | $770.4K | $667.1K |
| Total operating expenses | $14.1M | $13.8M | $13.0M | $15.4M | $4.3M | $1.4M | $1.6M | $1.3M | $770.4K | — |
| Operating income | -$14.0M | -$13.8M | -$13.2M | -$14.0M | -$3.9M | -$1.4M | -$1.6M | -$1.3M | -$579.8K | -$667.1K |
| Interest expense | $711.9K | $616.5K | $144.2K | $53.5K | $18.7K | $10.7K | — | $4.0K | $37.6K | $2.9K |
| Pre-tax income | -$14.8M | -$14.9M | -$13.8M | -$14.0M | -$21.2K | -$10.2K | -$1.6M | — | — | -$670.0K |
| Income tax | $800 | $800 | $800 | $0 | — | $0 | $0 | — | — | $0 |
| Net income | -$14.8M | -$14.9M | -$13.8M | -$14.0M | -$3.9M | -$1.5M | -$1.6M | -$1.3M | -$617.4K | -$670.0K |
| EPS, basic | -3.46 | -7.82 | -3.36 | — | — | — | — | — | — | — |
| EPS, diluted | -3.46 | -7.82 | -3.36 | — | -0.03 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 |
| Shares, diluted (wtd. avg.) | 4.3M | 1.9M | 4.1M | — | — | — | — | — | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $417.4K | $3.9M | $1.9M | $1.9M | $1.8M | $22.2K | $409.0K | $1.3M | $2.0M | $134.1K |
| Receivables | $22 | $56 | $455 | $201.5K | $0 | — | — | — | — | — |
| Inventory | $295.6K | $143.8K | $167.6K | $595.2K | $0 | $0 | $4.1K | — | $22.7K | $14.7K |
| Total current assets | $1.1M | $4.3M | $2.5M | $2.8M | $2.2M | $76.4K | $445.3K | $1.3M | $2.1M | $262.4K |
| Property, plant and equipment | $343.3K | $559.6K | $876.6K | $1.4M | $1.2M | $3.2K | $5.1K | $14.0K | $27.0K | $44.2K |
| Other intangibles | $19.2M | $23.7M | $28.3M | $32.8M | $37.3M | $180.6K | $146.3K | $146.5K | $182.4K | $156.1K |
| Total assets | $20.9M | $28.8M | $31.8M | $37.1M | $40.8M | $260.3K | $596.6K | $1.5M | $2.3M | $462.7K |
| Accounts payable | — | — | — | — | — | $145.6K | $208.7K | $115.3K | $159.3K | $168.8K |
| Total current liabilities | $1.1M | $4.0M | $1.3M | $2.5M | $30.6M | $1.1M | $753.3K | $733.6K | $1.8M | $1.3M |
| Total liabilities | $13.3M | $13.3M | $7.4M | $2.5M | $30.6M | $1.1M | $753.3K | $733.6K | $1.8M | $1.3M |
| Retained earnings | -$67.5M | -$52.7M | -$37.9M | -$24.1M | -$10.1M | -$6.2M | -$4.8M | -$3.2M | -$1.9M | -$1.3M |
| Total equity | $7.6M | $15.5M | $24.4M | $34.6M | $10.2M | -$838.3K | -$156.7K | $730.1K | $470.8K | -$809.9K |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$4.6M | -$5.8M | -$4.7M | -$3.0M | -$1.2M | -$499.6K | -$909.5K | -$1.0M | -$484.6K | -$520.8K |
| Depreciation and amortisation | $243.0K | $252.5K | $328.9K | $291.7K | $31.4K | $1.8K | $10.6K | $17.9K | $17.2K | $9.3K |
| Stock-based compensation | $1.7M | $3.5M | $1.1M | $6.4M | -$10.7K | $150.4K | $0 | $100.4K | $106.2K | — |
| Capital expenditure | $34.6K | $21.3K | $93.0K | $633.8K | $143.8K | $0 | $1.6K | $4.9K | — | $47.7K |
| Investing cash flow | -$2.2K | -$125.3K | -$101.5K | -$630.2K | -$180.5K | -$7.2K | -$13.1K | -$7.3K | -$49.1K | -$148.3K |
| Financing cash flow | $1.0M | $8.0M | $4.9M | $3.9M | $3.2M | $120.0K | $55.0K | $255.0K | $2.4M | $782.1K |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-013579.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $250.9K | $77.7K | $11.7K | $16.6K | $594.6K | $3.5M | $122.1K | $20.7K | $124.2K |
| Gross profit | — | $190.6K | $12.8K | $3.0K | $5.3K | $410.4K | $1.4M | -$253.7K | -$31.9K | $102.9K |
| Net income | -$670.0K | -$617.4K | -$1.3M | -$1.6M | -$1.5M | -$3.9M | -$14.0M | -$13.8M | -$14.9M | -$14.8M |
Recent filings and events
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Auditor changed The company changed auditors. Sometimes routine; historically one of the more reliable warnings that something is wrong. Item 4.01
- New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
- Results announced Item 2.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Results announced Item 2.02
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Unregistered share sale Shares issued outside a registered offering. Dilution, and for a small company often the way it is funded. Item 3.02
- Results announced Item 2.02
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 3577
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PANW | Palo Alto Networks Inc | $310.15B | 237.8x | 14.9% |
| FTNT | Fortinet, Inc. | $132.06B | 74.4x | 14.2% |
| LOGI | LOGITECH INTERNATIONAL S.A. | $15.70B | 22.8x | 6.3% |
| CRSR | Corsair Gaming, Inc. | $1.49B | — | 11.9% |
| MITK | MITEK SYSTEMS INC | $841.1M | 98.1x | 4.4% |
| EVLV | Evolv Technologies Holdings, Inc. | $836.8M | — | 40.5% |
| XRX | Xerox Holdings Corp | $336.2M | — | 12.9% |
| IMMR | IMMERSION CORP | $236.3M | 50.9x | 11.2% |